China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong
· Delayed Price · Currency is HKD 4.510
-0.040 (-0.88%)
Mar 10, 2026, 11:54 AM HKT
HKG:3320 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 28,585 | 35,810 | 32,229 | 39,705 | 22,303 | 25,004 | Upgrade
|
| Market Cap Growth | -16.21% | 11.11% | -18.83% | 78.03% | -10.80% | -44.97% | Upgrade
|
| Enterprise Value | 153,019 | 134,493 | 125,637 | 127,867 | 104,251 | 93,118 | Upgrade
|
| Last Close Price | 4.55 | 5.55 | 4.76 | 5.74 | 3.11 | 3.41 | Upgrade
|
| PE Ratio | 9.32 | 10.10 | 7.59 | 10.03 | 5.92 | 7.58 | Upgrade
|
| Forward PE | 7.03 | 7.10 | 6.11 | 8.75 | 5.81 | 6.69 | Upgrade
|
| PS Ratio | 0.10 | 0.13 | 0.12 | 0.16 | 0.09 | 0.13 | Upgrade
|
| PB Ratio | 0.23 | 0.34 | 0.32 | 0.44 | 0.24 | 0.31 | Upgrade
|
| P/TBV Ratio | 1.78 | 1.78 | 1.63 | 2.09 | 1.20 | 1.27 | Upgrade
|
| P/FCF Ratio | 1.52 | 2.26 | 2.25 | 4.11 | 2.14 | 3.83 | Upgrade
|
| P/OCF Ratio | 1.30 | 1.92 | 1.88 | 3.25 | 1.74 | 3.05 | Upgrade
|
| PEG Ratio | 1.08 | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 | Upgrade
|
| EV/Sales Ratio | 0.54 | 0.49 | 0.47 | 0.52 | 0.44 | 0.47 | Upgrade
|
| EV/EBITDA Ratio | 8.92 | 8.64 | 8.40 | 9.68 | 8.73 | 8.40 | Upgrade
|
| EV/EBIT Ratio | 11.59 | 10.55 | 10.34 | 11.61 | 10.59 | 9.98 | Upgrade
|
| EV/FCF Ratio | 8.11 | 8.49 | 8.75 | 13.24 | 10.00 | 14.24 | Upgrade
|
| Debt / Equity Ratio | 0.74 | 0.70 | 0.67 | 0.70 | 0.72 | 0.69 | Upgrade
|
| Debt / EBITDA Ratio | 5.40 | 4.50 | 4.38 | 4.59 | 5.37 | 4.69 | Upgrade
|
| Debt / FCF Ratio | 4.82 | 4.63 | 4.77 | 6.61 | 6.52 | 8.44 | Upgrade
|
| Net Debt / Equity Ratio | 0.46 | 0.44 | 0.32 | 0.42 | 0.41 | 0.46 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.52 | 2.96 | 2.21 | 2.88 | 3.22 | 3.34 | Upgrade
|
| Net Debt / FCF Ratio | 2.99 | 2.91 | 2.30 | 3.94 | 3.69 | 5.67 | Upgrade
|
| Asset Turnover | 0.94 | 1.02 | 1.06 | 1.00 | 1.03 | 1.00 | Upgrade
|
| Inventory Turnover | 5.57 | 6.30 | 7.07 | 6.99 | 7.42 | 7.17 | Upgrade
|
| Quick Ratio | 1.05 | 1.03 | 1.00 | 0.94 | 0.95 | 0.92 | Upgrade
|
| Current Ratio | 1.41 | 1.41 | 1.33 | 1.25 | 1.25 | 1.20 | Upgrade
|
| Return on Equity (ROE) | 7.57% | 8.80% | 8.96% | 8.09% | 7.60% | 7.12% | Upgrade
|
| Return on Assets (ROA) | 2.66% | 2.97% | 2.98% | 2.80% | 2.69% | 2.92% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.53% | 6.97% | 7.32% | 6.96% | 6.12% | 6.12% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.30% | 9.50% | 9.80% | 10.40% | 9.20% | 10.80% | Upgrade
|
| Earnings Yield | 10.73% | 9.96% | 13.18% | 9.97% | 16.90% | 13.19% | Upgrade
|
| FCF Yield | 65.97% | 44.25% | 44.53% | 24.32% | 46.76% | 26.14% | Upgrade
|
| Dividend Yield | 3.13% | 2.59% | 3.56% | 2.79% | 4.82% | 3.52% | Upgrade
|
| Payout Ratio | 52.74% | 44.44% | 22.83% | 23.23% | 20.00% | 20.96% | Upgrade
|
| Buyback Yield / Dilution | - | - | - | - | 0.01% | 0.02% | Upgrade
|
| Total Shareholder Return | 3.13% | 2.59% | 3.56% | 2.79% | 4.83% | 3.54% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.